Healthcare provider profile · identity verified

Richard Veerman, M.D.

Family Practice · FLORENCE, OR · NPI 1568823482

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	622	186
Levothyroxine Sodium	Levothyroxine Sodium	454	121
Lisinopril	Lisinopril	448	125
Amlodipine Besylate	Amlodipine Besylate	438	128
Losartan Potassium	Losartan Potassium	322	91
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	301	46
Gabapentin	Gabapentin	258	86
Omeprazole	Omeprazole	229	72
Rosuvastatin Calcium	Rosuvastatin Calcium	220	62
Metoprolol Succinate	Metoprolol Succinate	205	59
Trazodone Hcl	Trazodone Hcl	189	48
Metformin Hcl	Metformin Hcl	184	49
Furosemide	Furosemide	180	49
Hydrochlorothiazide	Hydrochlorothiazide	173	56
Carvedilol	Carvedilol	172	46
Eliquis	Apixaban	165	47
Potassium Chloride	Potassium Chloride	160	50
Pantoprazole Sodium	Pantoprazole Sodium	150	47
Albuterol Sulfate Hfa	Albuterol Sulfate	138	55
Duloxetine Hcl	Duloxetine Hcl	138	36
Oxycodone Hcl	Oxycodone Hcl	137	24
Warfarin Sodium	Warfarin Sodium	135	41
Tamsulosin Hcl	Tamsulosin Hcl	134	49
Allopurinol	Allopurinol	125	29
Sertraline Hcl	Sertraline Hcl	122	35
Simvastatin	Simvastatin	113	29
Metoprolol Tartrate	Metoprolol Tartrate	107	31
Pravastatin Sodium	Pravastatin Sodium	97	25
Spironolactone	Spironolactone	96	28
Lovastatin	Lovastatin	94	24
Celecoxib	Celecoxib	93	32
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	85	26
Triamcinolone Acetonide	Triamcinolone Acetonide	84	66
Pioglitazone Hcl	Pioglitazone Hcl	80	23
Atenolol	Atenolol	79	19
Finasteride	Finasteride	79	26
Bupropion Xl	Bupropion Hcl	75	22
Tramadol Hcl	Tramadol Hcl	73	21
Baclofen	Baclofen	70	14
Metformin Hcl Er	Metformin Hcl	70	24
Prednisone	Prednisone	70	35
Ozempic	Semaglutide	65	18
Irbesartan	Irbesartan	64	22
Citalopram Hbr	Citalopram Hydrobromide	63	17
Fluoxetine Hcl	Fluoxetine Hcl	63	19
Diclofenac Sodium	Diclofenac Sodium	61	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	59	14
Jardiance	Empagliflozin	58	18
Venlafaxine Hcl Er	Venlafaxine Hcl	57	14
Escitalopram Oxalate	Escitalopram Oxalate	56	21
Meloxicam	Meloxicam	56	23
Pregabalin	Pregabalin	56	13
Alprazolam	Alprazolam	55	22
Zolpidem Tartrate	Zolpidem Tartrate	55	suppressed
Clonazepam	Clonazepam	54	suppressed
Montelukast Sodium	Montelukast Sodium	54	15
Tizanidine Hcl	Tizanidine Hcl	54	16
Famotidine	Famotidine	53	21
Clopidogrel	Clopidogrel Bisulfate	51	15
Propranolol Hcl Er	Propranolol Hcl	50	11
Glipizide	Glipizide	49	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	49	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	48	16
Fluticasone Propionate	Fluticasone Propionate	48	22
Glimepiride	Glimepiride	48	13
Estradiol	Estradiol	45	13
Lorazepam	Lorazepam	45	16
Donepezil Hcl	Donepezil Hcl	44	suppressed
Glipizide Er	Glipizide	44	12
Ketoconazole	Ketoconazole	42	26
Doxepin Hcl	Doxepin Hcl	39	14
Ezetimibe	Ezetimibe	39	16
Nortriptyline Hcl	Nortriptyline Hcl	39	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	11
Buspirone Hcl	Buspirone Hcl	37	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	35
Chlorthalidone	Chlorthalidone	36	13
Ibuprofen	Ibuprofen	36	suppressed
Synthroid	Levothyroxine Sodium	36	suppressed
Klor-Con M20	Potassium Chloride	33	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	33	12
Ipratropium Bromide	Ipratropium Bromide	31	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Clonidine Hcl	Clonidine Hcl	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Propranolol Hcl	Propranolol Hcl	30	suppressed
Xarelto	Rivaroxaban	30	suppressed
Methocarbamol	Methocarbamol	29	17
Alendronate Sodium	Alendronate Sodium	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	12
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	25	16
Terazosin Hcl	Terazosin Hcl	25	suppressed
Verapamil Er	Verapamil Hcl	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	12
Ondansetron Odt	Ondansetron	24	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	18
Memantine Hcl	Memantine Hcl	23	suppressed
Telmisartan	Telmisartan	23	suppressed
Topiramate	Topiramate	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Diazepam	Diazepam	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	22	suppressed
Morphine Sulfate Er	Morphine Sulfate	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Acyclovir	Acyclovir	21	12
Azelastine Hcl	Azelastine Hcl	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Np Thyroid	Thyroid,pork	21	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Flecainide Acetate	Flecainide Acetate	19	suppressed
Methenamine Hippurate	Methenamine Hippurate	19	suppressed
Ramipril	Ramipril	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Mupirocin	Mupirocin	18	suppressed
Calcitriol	Calcitriol	17	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Risperidone	Risperidone	16	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Prazosin Hcl	Prazosin Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Torsemide	Torsemide	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Cilostazol	Cilostazol	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error